Adventist Health System of West v. Abbvie Inc.

Good Law
United States Court of Appeals for the Ninth CircuitMarch 17, 202624-2180California4,917 words

Opinion

Opinion

Desai, J.

FOR PUBLICATION

UNITED STATES COURT OF APPEALS

FOR THE NINTH CIRCUIT

United States of America ex rel. No. 24-2180

ADVENTIST HEALTH SYSTEM OF

WEST, Relator, on behalf of the State D.C. No. 2:21-cv- of California and other States, 04249-DSF-SK

Plaintiff - Appellant,

OPINION

v.

ABBVIE INC.; ALLERGAN SALES,

LLC; ALLERGAN USA, INC.;

ASTRAZENECA, LP;

ASTRAZENECA

PHARMACEUTICALS, LP;

NOVARTIS PHARMACEUTICALS

CORPORATION; SANDOZ GROUP

AG; GENZYME CORPORATION;

SANOFI US SERVICES INC.;

SANOFI-AVENTIS U.S. LLC;

NOVARTIS AG; SANOFI S.A.,

Defendants - Appellees.

Appeal from the United States District Court for the Central District of California Dale S. Fischer, District Judge, Presiding Submitted April 10, 2025* Pasadena, California

Filed March 17, 2026

Before: Consuelo M. Callahan, Roopali H. Desai, and Ana de Alba, Circuit Judges.

Opinion by Judge Desai

SUMMARY**

False Claims Act

The panel reversed the district court’s dismissal for failure to state a claim and remanded for further proceedings in a qui tam action brought by Adventist Health System of West, asserting violations of the False Claims Act and state law analogues…

Sign in to read the full opinion

Create a free account to read the complete opinion text, citation history, and good-law status for this case.